Sarah DeDiemar on the commercialization of PancreaSure
In September 2025, Immunovia launched PancreaSure®, the company’s blood test to detect pancreatic cancer...
Published: 5 November, 2026
Tyvärr, ingenting matchar den här kategorin.
In September 2025, Immunovia launched PancreaSure®, the company’s blood test to detect pancreatic cancer...
Published: 5 November, 2026
Immunovia's CEO Jeff Borcherding sees the rights issue as the next step following the launch of PancreaSure...
Published: 29 September, 2026
Published: 6 August, 2026
2025 – The year Immunovia launched PancreaSure and transitioned to a commercial company.
Published: 10 April, 2026